JPS523050A - Production of 11 betaa fluorrandrostene and androgenic agent containing the same* - Google Patents

Production of 11 betaa fluorrandrostene and androgenic agent containing the same*

Info

Publication number
JPS523050A
JPS523050A JP51074982A JP7498276A JPS523050A JP S523050 A JPS523050 A JP S523050A JP 51074982 A JP51074982 A JP 51074982A JP 7498276 A JP7498276 A JP 7498276A JP S523050 A JPS523050 A JP S523050A
Authority
JP
Japan
Prior art keywords
fluorrandrostene
betaa
production
same
agent containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51074982A
Other languages
Japanese (ja)
Inventor
Hoofumaisutaa Herumuuto
Raurento Henrii
Buiiheruto Ruudorufu
Annen Kurausu
Shiyutainbetsuku Heruman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of JPS523050A publication Critical patent/JPS523050A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP51074982A 1975-06-25 1976-06-24 Production of 11 betaa fluorrandrostene and androgenic agent containing the same* Pending JPS523050A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752528879 DE2528879A1 (en) 1975-06-25 1975-06-25 11 BETA FLUOR ANDROSTENS

Publications (1)

Publication Number Publication Date
JPS523050A true JPS523050A (en) 1977-01-11

Family

ID=5950147

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51074982A Pending JPS523050A (en) 1975-06-25 1976-06-24 Production of 11 betaa fluorrandrostene and androgenic agent containing the same*

Country Status (8)

Country Link
JP (1) JPS523050A (en)
BE (1) BE843437A (en)
DD (1) DD124988A5 (en)
DE (1) DE2528879A1 (en)
DK (1) DK252276A (en)
FR (1) FR2316958A1 (en)
LU (1) LU75229A1 (en)
NL (1) NL7606822A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59116417A (en) * 1982-12-17 1984-07-05 イ−・アイ・デユポン・デ・ニモアス・アンド・カンパニ− Polyester/nylon two-component filament

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59116417A (en) * 1982-12-17 1984-07-05 イ−・アイ・デユポン・デ・ニモアス・アンド・カンパニ− Polyester/nylon two-component filament

Also Published As

Publication number Publication date
LU75229A1 (en) 1977-02-18
DE2528879A1 (en) 1977-01-13
NL7606822A (en) 1976-12-28
BE843437A (en) 1976-12-27
FR2316958A1 (en) 1977-02-04
DD124988A5 (en) 1977-03-23
DK252276A (en) 1976-12-26

Similar Documents

Publication Publication Date Title
JPS55349A (en) Novel 44*or 55 or 77* benzoylindolinee22one and its manufacture
JPS5233675A (en) 1*2*44triazol compound and antiibacterial composition containing the same
GB1543821A (en) Elastomers of the ethylene-propylene-termonomers and articles comprising such elastomers
JPS5231063A (en) Production of novel 17 betaaester of nandrolone and novel pharmaceutical agent containing same with assimirating action
JPS5251367A (en) Production of novel substituted 44aminopyrazole and pharmaceutical agent containing the same
JPS5271485A (en) 3*44dihydrooquinazoline derivatives and their production and composition having antiiallergy effect containing same
JPS5210243A (en) Compositions and process
YU173376A (en) 3-oxime-esters of d-17-ethylene-19-nortestosterone and process for the manufacture thereof
JPS5248647A (en) Compositions and process
JPS51131880A (en) 11*3*3*33triarylpropyl**44 phenyll44piperidinemethanol and analogous compounds
JPS52105168A (en) Production of 1*22 benzisothiazolinee33ones and use of same as pharmaceutical agent
JPS5246068A (en) Production of llleucinee 133mochilin and compound containing the same
JPS5259194A (en) Production of novel 66aryll sstriazoloo*4*33a* pyridd *2*33f**1*44diazepine and antiiconvulsion agent containing same
JPS5223081A (en) 1*44dihydropyridines and application to remedy
JPS51141862A (en) Production of cardenolide derivatives and pharmaceutical composition containing the same
JPS51125383A (en) Production of thiazolinone and pharmaceutical composition containing the same
JPS51136664A (en) Novel 33deoxyy14 betaa hydroxycaldenolide and production of the same
JPS5235223A (en) Powdered coating agent and production thereof
JPS5238541A (en) Powdered coating agent and production thereof
JPS5238542A (en) Powdered coating agent and production thereof
JPS5223010A (en) Preparation and use of 1*11 dichlorr44methyll33hydroxyy bentt11en
JPS5359654A (en) Novel derivatives of 99 chlorpredonisolone * production of same and pharmaceutical agent containing the same with strong antiiinflammatory acti1on
JPS52113983A (en) *22pyrimidinyllthioalkanoneamide*its production and antiilipemic agent containing same
JPS51149272A (en) 44oxooimidazolidinehydroxide * production thereof and stabilizing composition containing the same
JPS523050A (en) Production of 11 betaa fluorrandrostene and androgenic agent containing the same*